Shareholders Shanghai Tan Ying and Shanghai Tan Zheng of JUNSHI BIO (688180.SH) collectively reduced their stake in the company by 0.75%.
Kim Il-sen Biological (688180.SH) announced that the company received a notice from its shareholder Shanghai Tan... on November 12, 2024.
JUNSHI BIO (688180.SH) announced that on November 12, 2024, the company received a notice from shareholders Shanghai Tan Ying and Shanghai Tan Zheng regarding the completion of the reduction plan and the results of the reduction of shares. From October 23, 2024 to November 12, 2024, Shanghai Tan Ying and Shanghai Tan Zheng collectively reduced the company's A shares by 7.3927 million shares through centralized bidding, accounting for 0.75% of the total share capital of the company. As of November 12, 2024, the reduction plan has been completed.
Related Articles
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
